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Abstract: To compare two different procedures, mid-urethral mini sling (Ophira) 
and autologous rectus fascia sling, according to their medium-term subjective 
and objective outcome and satisfaction rates in the treatment of stress urinary 
incontinence in women. One hundred women with the main complaint of stress 
urinary incontinence were randomized to be treated with either mini sling 
(Ophira) or autologous rectus facia pubovaginal sling. Preoperative evaluation 
consisted of: physical examination, blood biochemistry urine analysis and 
culture, urinary tract ultrasound scan, conventional multi-channel urodynamic 
study, cystourethroscopy, cough induced stress test and Incontinence Impact 
Questionnaire (IIQ). The patients were objectively and subjectively re-evaluated 
at 1, 3, 6 and 12 postoperative months and the last visit and the collected data 
of more than one year follow-up were compared with preoperative assessments. 
Seventy two out of one hundred patients were followed for a mean time of 
13.8 ± 4.4 months (12–20 months range). Objective cure rate, according to  
cough-induced stress test was recorded in 88.6% and 89.2% of the mini sling 
(Ophira) and the rectus facia sling group respectively (P=1.0). Postoperative mean 
IIQ score decreased to 42.7 ± 11.4 and 50.2 ± 11.1 in the mini sling (Ophira) 
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group versus rectus facia pubovaginal sling (P=0.007). Twenty eight (80%) and 
23 (67%) patients in the mini sling (Ophira) and rectus facia pubovaginal sling were 
satisfied with the operation (P=0.23). There is no significant difference between the 
mini sling (Ophira) and autologous rectus fascia sling procedure in the treatment  
of stress urinary incontinence at medium-term follow-up.
Introduction
Stress urinary incontinence (SUI) is the most common complaint of adult women 
with reported prevalence of up to 40% in large epidemiological surveys (Mostafa  
et al., 2012). SUI has a negative impact on quality of life and represents an 
important economic burden, as a social health problem (Gauruder-Burmester 
and Popken, 2009). Conservative managements such as pelvic floor muscle 
training, biofeedback and electrical stimulation may improve the problem, though 
persistence in therapy is needed (Sharifiaghdas and Mortazavi, 2008). However, 
for most of the women, surgery remains the basis of SUI management (Zoorob 
and Karram, 2012). Over the past decade, rectus facia pubovaginal sling has been 
introduced as the gold standard approach with high success rate even in the 
complicated and recurrent cases. However, the complications associated with 
this approach (e.g. bladder perforation, bleeding and wound infection) are still 
noted in up to 20% of the cases (Blaivas and Chaikin, 2011). Various minimally 
invasive procedures such as mid-urethral mini slings have been used recently in 
the treatment of SUI to overcome the possible morbidities. In these procedures, 
passage of the trocars through the retropubic or trans-obturator space is avoided 
with the intent to decrease postoperative pain and potential adverse events (Taub 
et al., 2005). Ophira mini sling system (Promedon, Argentina) is a rather new 
device which places a mid-urethral tension free polypropylene tape anchored to 
the urethropelvic ligament (retropubic approach) or obturator internus muscles 
bilaterally at the level of tendinous arc. The anchoring system is a specially designed 
fish bone like system at the end of each arm.
It is told that this system offers a very low perioperative complication rate, 
reduced hospital stay and operative time without jeopardizing the success rate 
(Abdel-Fattah et al., 2012). A few studies evaluated the efficacy and safety of this 
procedure in the treatment of SUI (Abdel-Fattah et al., 2011), however there is no 
randomized clinical trial report on this procedure in comparison with other gold 
standard techniques.
In this clinical trial, the safety and efficacy of Ophira mini sling was compared to 
pubovaginal rectus facia sling as a gold standard surgery in the treatment of women 
suffering from SUI.
Material and Methods
From January 2009 to December 2011, seventy two patients with the main 
complaint of SUI were enrolled in a prospective study. The inclusion criteria 
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was: history of SUI, unresponsive to conservative managements, with urethral 
hypermobility and a positive cough stress test at equal to or more than 300 ml 
bladder capacity. Preoperative evaluation consisted of: physical examination 
including pelvic floor evaluation in the lithotomy position, cough stress test, Q-tip 
test.
Multi-channel urodynamic study and cystourethroscopy was performed in all. 
Paraclinic imaging and tests including urinary tract ultrasound scan, complete blood 
count (CBC), renal and liver function tests, serum electrolytes, urine analysis and 
culture was done in all.
Symptoms were scored according to the Incontinence Impact Questionnaire 
(IIQ) of Shumaker and colleagues (1994).
The degree of pelvic floor weakness was scored according to the pelvic organ 
prolapse quantification system (POP-Q) (Palma et al., 2010, 2012, 2013).
Hypermobility was defined as more than or equal to 45 degree change in 
the angle of urethra to horizontal line. Baseline demographic data including age, 
parity, menopausal status, body mass index (BMI), past medical history and pelvic 
surgeries were recorded.
Exclusion criteria were: persistent urinary tract infection (UTI) or active UTI at 
the time of surgery, evidences of urogynecological malignancies, cystocele grade 
of equal to or more than 3, history of neurogenic bladder, abnormal filling or 
voiding phase in the urodynamic study (low capacity, low compliance, or detrusor 
overactivity, maximum flow rates of lower than 15 ml/s and residual urine of more 
than 100 milliliters), abnormal cystourethroscopy findings (trabeculated bladder, and 
or open bladder neck). The clinical study was approved by the Ethics Committee 
of the Urology and Nephrology Research Center (UNRC) of Shahid Labbafinejad 
Medical Center. Patients were randomly assigned to each group of Ophira mini 
sling versus standard rectus facia pubovaginal sling by envelope sealed cards.
Surgical technique
All procedures were carried out under spinal anesthesia in a lithotomy position. 
An experienced urologist (F. Sharifiaghdas) accomplished all the operations 
in the pubovaginal sling group; after creation of Pfannenstiel skin incision; 
a 6–8 cm × 1–1.5 cm strip of the anterior rectus facia sheet was harvested. At the 
next steps, two parallel longitudinal incisions of about 1–1.5 cm were made on 
the anterior vaginal wall mucosa; at the level of the proximal urethra and lateral to 
the bladder neck.
After creation of a submucosal tunnel, the harvested facial graft was passed 
through the tunnel, and placed beneath the vaginal mucosa. The arms of graft were 
sutured by vicryl at the both ends and brought to the retropubic area. The long 
ends of vicryl sutures were tied to each other in the midline securing the sling in 
place without any tension (2 finger placed under the suprapubic midline knot). The 
anterior vaginal wall was checked to prevent overcorrection (the anterior vaginal 
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wall should not move to the superior or posterior directions). At the end of the 
procedure, a 16-French Foley catheter was passed through the urethra and fixed 
in place. The urethral catheter was removed 1–3 days postoperative after the first 
attempts to void, residual urine was measured by clean catheterization and the 
patient was discharged if post-void residual urine was less than 100 ml.
In the Ophira mini sling group, a vertical incision of 1 cm was made on the 
anterior vaginal wall mucosa at the level of the mid urethra.
A gentle minimal dissection was made towards the inferior ramus of pubic bone. 
The delivery trocar was attached to the arms of mini sling mesh, guided by the 
surgeon’s index finger towards the urethra-pelvic ligament. When half the length of 
the mesh was within the incision, the deploying button at the handle of the trocar 
was retracted to make a strong fixation of the mini sling mesh in the place. The 
same steps were repeated on the other side.
Foley catheter was left in place and removed 6 to 48 hours postoperative. All 
patients in both groups underwent cystourethroscopy during the procedure to rule 
out urethral or bladder penetration.
The patients were visited and followed-up regularly at one week and 1, 3, 6 and 
12 months postoperative.
At each visit they were examined and re-evaluated by objective measures (cough 
stress test with a full bladder) and subjective means (IIQ scores). The women 
were asked to describe their satisfaction from the surgery, on a visual analogue 
scale of 0–10, whether or not they would have the procedure repeated if their 
incontinence returned, and whether they would recommend the procedure to 
a friend. A visual analogue scale of 8–10 and positive answers to another two 
questions were defined as satisfaction. The complications were recorded. Urine 
culture and ultrasound was repeated at each visit. Residual urine of more than 
100 ml was considered significant. Data analysis was performed by using SPSS 
software (Statistical Package for the Social Sciences, v16.0; SPSS Inc., Chicago, 
IL, USA). Student’s t-test and chi-square test were used. A P-value of < 0.05 was 
considered as statistically significant.
Results
Seventy two patients with the main complaint of SUI were followed for a mean 
time of 13.8 ± 4.4 months (12–20 months range).
Demographic and clinical characteristics of patients are shown in Table 1. The 
average patient’s age (±SD) in the sling and Ophira group were 52.2 ± 9.3 and 
55.6 ± 9.8 years, respectively (P=0.13).
There was no statistically significant difference between two groups regarding 
parameters including: weight, duration of urinary incontinence, number of vaginal 
deliveries, past obstetric history, hysterectomy and incontinence surgery. In terms 
of the preoperative functional results mean scores (±SD) of Valsalva leak point 
pressure (VLPP) and maximum flow rate (Qmax) were 97 ± 33.8 cm H2O vs. 
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100.7 ± 37 cm H2O (P=0.66) and 25 ± 5.9 ml/s vs. 27.2 ± 6.5 ml/s (P=0.14) in the 
sling and Ophira groups, respectively (Table 1).
Table 2 shows the detailed perioperative variables as well as the peri- and 
post-operative complications associated with both procedure the operation time 
was 65.6 ± 22.6 minutes vs. 12.9 ± 11.3 minutes in the sling and Ophira groups, 
respectively (P=0.0001). Postoperative hospital stay was 36.6 ± 14.4 hours vs. 
7.8 ± 1.1 hours, respectively (P=0.0001).
The mean ± SD Foley catheterization time in the sling and Ophira groups was 
32.4 ± 12.5 and 10.8 ± 2.3 hours, respectively (P=0.0001).
Five (13.5%) and six (16.2%) patients in the sling group complained of urge 
incontinence and obstructive voiding symptoms respectively, while those 
complaints were recorded for one patient of Ophira group (2.9%). All patients with 
obstructive symptoms were managed conservatively at first (anti-inflammatory 
drugs, CIC). Urethral dilation was performed for 1 patient. No patient was 
under clean intermittent catheterization. Four patients in each group reported 
some degrees of SUI at one year post operation. Cough stress test was positive 
in 4 (10.81%) and 4 (11.42%) of the patients in the sling and Ophira groups 
respectively. There was no statistically significant difference between two groups in 
terms of dyspareunia, bladder perforation, urethral erosion, vaginal erosion-wound 
hematoma and/or infection was recorded in 21.6% and 2.9% of sling and Ophira 
group respectively (P=0.03), all treated conservatively (antibiotics, local care and 
dressings). Vaginal erosion of the mesh was observed in two cases (5.7%) of Ophira 
group 7 and 8 months postoperative, treated by partial excision of the eroded tape 
and repair of vaginal wall.
Table 1 – Demographic data of patients in two groups of patients treated 
by rectus fascia sling versus mini sling Ophira device
Variable Ophira group
(n=35)
Sling group
(n=35)
P-value
Age average (year) (±SD)
Weight average (kg) (±SD)
C/S history (%)
NVD (min–max)
Duration of incontinency 
average (year) (±SD)
Hysterectomy (%)
Incontinency surgery (%)
Marshal positive test (%)
VLPP average (±SD)
Qmax average (ml/s) (±SD)
Average IIQ score (min–max)
55.6 ± 9.8
71.7 ± 11.4
9 (25.7%)
3 (0–6)
2.4 ± 1.5
3 (8.6%)
1 (2.9%)
29 (82.9%)
100.7 ± 37.5
27.2 ± 6.5
67.3 (50–80)
52.2 ± 9.3
72.4 ± 9.8
9 (24.3%)
4 (1–8)
2.8 ± 2.1
3 (8.1%)
3 (8.1%)
34 (91.1%)
97.0 ± 33.8
25.0 ± 5.9
69.9 (49–87)
0.13
0.77
0.65
0.66
0.37
0.10
0.61
0.30
0.66
0.14
0.34
C/S – caesarean section; NVD – normal vaginal delivery; VLPP – Valsalva leak point pressure; Qmax – maximum flow 
rate; IIQ – incontinence impact questionnaire
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Table 2 – Peri- and post-operation patients’ information in two groups  
of patients treated by rectus fascia sling versus mini sling Ophira device
Variable Ophira group
(n=35)
Sling group
(n=35)
P-value
Time of surgery (min) (±SD)
Admit day average (hour) (±SD)
12.9 ± 11.3
7.8 ± 1.1
65.6 ± 22.6
59.9 ± 11.4
0.0001
0.0001
Complication
Stress incontinence (%)
Urge incontinence (%)
Obstructive symptom (%)
UTI (%)
Hematoma and wound infection (%)
Pack cell infusion (%)
Dyspareunia (%)
Bladder perforation (%)
Urethral erosion (%)
Vaginal erosion (%)
4 (11.4%)
1 (2.9%)
1 (2.9%)
0 (0%)
1 (2.9%)
0 (0%)
4 (11.4%)
0 (0%)
0 (0%)
2 (5.7%)
4 (10.8%)
5 (13.5%)
6 (16.2%)
0 (0%)
8 (21.6%)
1 (2.7%)
3 (8.1%)
1 (2.7%)
0 (0%)
1 (2.7%)
1.000
0.200
0.100
1.000
0.030
1.000
0.700
1.000
1.000
0.610
Average IIQ score (±SD)
Preoperative
Postoperative
P-value
67.3 ± 8.2
42.7 ± 11.4
0.005
69.6 ± 9.6
50.2 ± 11.1
0.001
0.340
0.007
UTI – urinary tract infection; IIQ – incontinence impact questionnaire
Bladder penetration was discovered during the operation in one patient in the sling 
group which was managed by longer postoperative Foley catheterization (7 days).
Preoperative mean IIQ was 69.6 and 67.3 in the sling versus Ophira group which 
decreased to mean 50.2 ± 11.1 and 42.7 ± 11.4 after operation (P=0.007). Twenty 
eight (80%) and 25 (67.5%) of the patients in the Ophira and sling group were 
satisfied with the operation (P=0.23).
Discussion
New generation of single incision mid-urethral slings were introduced from 
last decade with the intent to cure stress urinary incontinence in an outpatient 
with short operation time, less pain and less bleeding (Palma et al., 2010, 2012, 
2013; Pushkar et al., 2010; Enzelsberger et al., 2011; Smith et al., 2011). Several 
clinical studies are ongoing to investigate the safety and efficacy of these new 
minimally invasive procedures compared to the gold standard surgeries, the Burch 
colposuspension and the pubovaginal slings with established high cure rates in the 
treatment of SUI. Despite high success rates with rectus facia pubovaginal sling 
even in complicated cases of SUI, there are some complications reported with this 
approach, such as wound infections, de novo urge incontinence and obstructive 
symptoms (Shumaker et al., 1994; Bump et al., 1996; Abrams et al., 2002; 
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Athanasopoulos et al., 2011; Enzelsberger et al., 2011; Palma et al., 2012; Sivaslioglu 
et al., 2012). Ophira mini sling is among the new innovative systems, proposed to 
overcome these drawbacks, omit graft harvest and reduce excessive tension on 
bladder neck (Cody et al., 2003).
There are a few published case series on Ophira mini sling in the treatment 
of SUI. Palma et al. (2010) reported their experience on 124 female patients 
who suffered from SUI with a mean age (±SD) of 54.7 ± 9.9 years old with a 
postoperative follow-up of at least 12 months. They used PAD test to objectively 
evaluate the surgical result. 81 (85.3%) patients were cured, 6 (6.3%) improved 
and 8 (8.4%) remained incontinent (Palma et al., 2010). Pushkar and his colleagues 
(2010) published their results with Ophira in thirty women and reported a 
negative cough stress test in 92.8% at 12 months postoperative follow-up. Djehdian 
et al. (2010) compared the efficacy and safety of Ophira and trans-obturator 
mid-urethral tape (TOT) in a randomized trial, 45 and 28 women were followed. 
The author did not find any differences in subjective cure rates between two 
groups, however objectively the percentage of patients with postoperative negative 
cough stress test was statistically lower in Ophira group (Djehdian et al., 2010). 
Also, in a prospective study by Smith et al. (2011), patient satisfaction and clinical 
efficacy of two procedures Ophira and trans-obturator tape were compared. The 
authors concluded that Ophira and TOT procedures were comparable in terms 
of both objective and subjective cure rates; however the major advantage of 
Ophira compared to TOT was the facility of performing the procedure under local 
anesthesia on an ambulatory basis with less postoperative pain and intraoperative 
complication (Smith et al., 2011). Sharifiaghdas and Mortazavi (2008) have 
compared tension-free vaginal tape (TVT) with rectus facia pubovaginal sling in 
61 patients (25 in the TVT and 36 in the sling group). The authors concluded that 
TVT and pubovaginal rectus facia sling were comparable in terms of both objective 
and subjective cure rate (Sharifiaghdas and Mortazavi, 2008). Our study showed an 
objective cure rate of 84.2% and 88.6% in the sling and Ophira groups respectively. 
Palma et al. (2012) proposed that the high load tolerated by Ophira mini sling is 
related to its multipoint fishbone-like polypropylene fixation device.
Conclusion
According to our data, it seems that the mini sling Ophira system and rectus facia 
pubovaginal sling procedures were comparable in terms of both objective and 
subjective cure rates. However the major advantages of Ophira compared to sling 
are shorter hospital stay, short duration of operation, less wound infection and 
more patient’s satisfaction.
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